EU-IN_VITRO_MEDICAL_DEVICES-ART_3_ANX_1

In Vitro Diagnostic Medical Devices Directive - Hazardous Substances

EU. Hazardous Substances for Purposes of Article 3 & Annex I (Essential Requirements), Directive 98/79/EC on In Vitro Diagnostic Medical Devices, 7 December 1998

This list contains a non-exhaustive inventory of hazardous substances for purposes of essential requirements (Article 3 and Annex I) for general safety, design, manufacture and hazard communication of in vitro diagnostic medical devices. It is derived from: Table 3 of Annex VI to CLP, REACH Candidate List of SVHCs, and Directive 2000/54/EC's Annex III (Biological Agents list). Note that Regulation 2017/746/EU on in vitro diagnostic medical devices was published in the EU Official Journal on 5 May 2017. With few exceptions specified in Articles 112 and 113 of this Regulation, Directive 98/79/EC is repealed, and the rules pursuant to 2017/746/EU apply, from 26 May 2022.

Last updated 04 listopada 2024. Database contains 4821 unique substances/entries.

Filter the list

Prikazano 901 - 1.000 od 4.821 rezultata.

Substance Name	EC No.	CAS No.	EU CLP (1272/2008)	EU_BA Directive 2000/54/EC	EU REACH: List of SVHC
reaction mass of: 1-deoxy-1-[methyl-(1-oxododecyl)amino]-D-glucitol; 1-deoxy-1-[methyl-(1-oxotetradecyl)amino]-D-glucitol (3:1) GA1270; HOE S 4096	407-290-1	-	Eye Dam. 1
reaction mass of: 1-(4-isopropylphenyl)-1-phenylethane; 1-(3-isopropylphenyl)-1-phenylethane; 1-(2-isopropylphenyl)-1-phenylethane	430-690-2	52783-21-8	Skin Irrit. 2
reaction mass of: 1-(1,1-dimethylpropyl)-4-ethoxy-cis-cyclohexane; 1-(1,1-dimethylpropyl)-4-ethoxy-trans-cyclohexane	426-530-6	-	Skin Irrit. 2
Reaction mass of: 1-(1'H,1'H,2'H,2'H-tridecafluorooctyl)-12-(1''H,1''H,2''H,2''H-tridecafluorooctyl)dodecanedioate; 1-(1'H,1'H,2'H,2'H-tridecafluorooctyl)-12-(1''H,1''H,2''H,2''H-heptdecafluorodecyl)dodecanedioate; 1-(1'H,1'H,2'H,2'H-tridecafluorooctyl)-12-(1''H,1''H,2''H,2''H-heneicosafluorododecyl)dodecanedioate; 1-(1'H,1'H,2'H,2'H-tridecafluorooctyl)-12-(1''H,1''H,2''H,2''H-pentacosafluorotetradecyl)dodecanedioate; 1-(1'H,1'H,2'H,2'H-heptadecafluorodecyl)-12-(1''H,1''H,2''H,2''H-heptadecafluorodecyl)dodecanedioate; 1-(1'H,1'H,2'H,2'H-heptadecafluorodecyl)-12-(1''H,1''H,2''H,2''H-heneicosafluorododecyl)dodecanedioate HFR-990	423-180-6	-	STOT RE 2
reaction mass of: 1,7-dimethyl-2-[(3-methylbicyclo[2.2.1]hept-2-yl)methyl]bicyclo[2.2.1]heptane; 2,3-dimethyl-2-[(3-methylbicyclo[2.2.1]hept-2-yl)methyl]bicyclo[2.2.1]heptane	427-040-5	-	Skin Corr. 1B
reaction mass of: 1,3,5-tris(3-aminomethylphenyl)-1,3,5-(1H,3H,5H)-triazine-2,4,6 trione; reaction mass of oligomers of; 3,5-bis(3-aminomethylphenyl)1-poly[3,5-bis(3-aminomethylphenyl)-2,4,6-trioxo-1,3,5-(1H,3H,5H)-triazin-1-yl]-1,3,5(1H,3H,5H)-triazine-2,4,6-trione BLENDUR I VP KU 3-4519	421-550-1	-	Carc. 1B; Repr. 1B; Skin Sens. 1
reaction mass of: 1,2-naphthoquinonediazide-5-sulfonylchloride (or sulfonic acid)monoester with 4,4'-(1-(4-(1-(4-hydroxyphenyl)-1-methylethyl)phenyl)ethylidene)bisphenol; 1,2-naphthoquinonediazide-5-sulfonylchloride(or sulfonicacid)diester with 4,4'-(1-(4-(1-(4-hydroxyphenyl)-1-methylethyl)phenyl)ethylidene)bisphenol; 1,2-naphthoquinonediazide-5-sulfonylchloride (or sulfonic acid)triester with 4,4'-(1-(4-(1-(4-hydroxyphenyl)-1-methylethyl)phenyl)ethylidene)bisphenol	433-640-8	-	Pyr. Sol. 1
reaction mass of: 1,2-dimethylpropylidene dihydroperoxide; dimethyl 1,2-benzenedicarboxylate	442-480-8	-	Org. Perox. C; Acute Tox. 4; Skin Corr. 1B; Skin Sens. 1
reaction mass of: (3R)-[1S-(1α,2α, 6β-((2S)-2-methyl-1-oxo-butoxy)-8aγ)hexahydro-2,6-dimethyl-1-naphthalene]-3,5-dihydroxyheptanoic acid; inert biomass from Aspergillus terreus LOVASTATIN FREE ACID	415-840-7	-	Skin Sens. 1
reaction mass of: (3-methoxy)propylammonium/[tris-(2-hydroxyethyl)]ammonium 2-(2-(bis(2-hydroxyethyl)amino)ethoxycarbonylmethyl)hexadec-4-enoate; (3-methoxy)propylammonium/ [tris-(2-hydroxyethyl)]ammonium 2-(2-(bis(2-hydroxyethyl)amino)ethoxycarbonylmethyl)tetradec-4-enoate; (3-methoxy)propylammonium/[tris-(2-hydroxyethyl)]ammonium 2-(3-methoxypropylcarbamoylmethyl)hexadec-4-enoate; (3-methoxy)propylammonium/ [tris-(2-hydroxyethyl)]ammonium 2-(3-methoxypropylcarbamoylmethyl)tetradec-4-enoate HOSTACOR 4205 CONC.; HOSTACOR V 4205	413-500-2	-	Skin Irrit. 2; Eye Dam. 1
reaction mass of: (2R, 3R)-3-(2-ethoxyphenoxy)-2-hydroxy-3-phenylpropylammonium methanesulfonate; (2S, 3S)-3-(2-ethoxyphenoxy)-2-hydroxy-3-phenylpropylammonium methanesulfonate	425-530-3	98769-75-6	Acute Tox. 4; Eye Dam. 1
reaction mass of: (1RS, 2SR,7SR, 8SR, E) 9 and 10-ethylidene-3-oxatricyclo[6.2.1.0(2,7)]undecan-4-one; (1RS, 2SR, 7SR, 8SR, Z)-10-ethylidene-3-oxatricyclo[6.2.1.0(2,7)]undecan-4-one; (1RS, 2SR, 7SR, 8SR, Z)-9-ethylidene-3-oxatricyclo[6.2.1.0(2,7)]undecan-4-one	434-290-9	249630-78-2	Acute Tox. 4
reaction mass of: (1RS, 2RS,3SR, 6RS, 9SR)-9-methoxytricyclo[5.2.1.0(2,6)]decane-3-carbaldehyde; (1RS, 2RS, 3RS, 6RS, 8SR)-8-methoxytricyclo[5.2.1.0(2,6)]decane-3-carbaldehyde; (1RS, 2RS, 4SR, 6RS, 8SR)-8-methoxytricyclo[5.2.1.0(2,6)]decane-4-carbaldehyde	429-860-9	86803-90-9	Skin Sens. 1
reaction mass of: (1'α, 3'α, 6'α)-2,2,3' ,7', 7'-pentamethylspiro(1,3-dioxane-5,2'-norcarane); (1'α, 3'β, 6'α)-2,2,3', 7', 7'-pentamethylspiro(1,3-dioxane-5,2'-norcarane) SPIRAMBRENE	416-930-9	121251-67-0	Skin Irrit. 2
reaction mass of: ((Z)-3,7-dimethyl-2,6-octadienyl)oxycarbonylpropanoic acid; di-((E)-3,7-dimethyl-2,6-octadienyl) butandioate; di-((Z)-3,7-dimethyl-2,6-octadienyl) butandioate; (Z)-3,7-dimethyl-2,6-octadienyl butandioate; ((E)-3,7-dimethyl-2,6-octadienyl)oxycarbonylpropanoic acid MS6119	415-190-4	-	Skin Sens. 1
reaction mass of α-3-(3-(2H-benzotriazol-2-yl)-5-tert-butyl-4-hydroxyphenyl)propionyl-ω-hydroxypoly(oxyethylene) and α-3-(3-(2H-benzotriazol-2-yl)-5-tert-butyl-4-hydroxyphenyl)propionyl-ω-3-(3-(2H-benzotriazol-2-yl)-5-tert-butyl-4-hydroxyphenyl)propionyloxypoly(oxyethylene) EVERSORB 80; TINUVIN 1130; TINUVIN 213	400-830-7	-	Skin Sens. 1
reaction mass of trisodium 3-(5-(2,6-difluoropyrimidin-4-ylamino)-2-sulfonatophenylazo)5-(4-fluoro-6-morpholin-4-yl-1,3,5-triazin-2-ylamino)-4-hydroxy-2,7-naphthalenedisulfonate; trisodium 3-(5-(4,6-difluoropyrimidin-2-ylamino)-2-sulfonatophenylazo)-5-(4-fluoro-6-morpholin-4-yl-1,3,5-triazin-2-ylamino)-4-hydroxy-2,7-naphthalenedisulfonate	436-890-6	-	Eye Dam. 1
reaction mass of pentyl methylphosphinate and 2-methylbutyl methylphosphinate MPA	402-090-0	87025-52-3	Skin Corr. 1B
reaction mass of O, O'-diisopropyl (pentathio)dithioformate and O, O'-diisopropyl (trithio)dithioformate and O, O'-diisopropyl (tetrathio)dithioformate ROBAC AS/100	403-030-6	137398-54-0	Acute Tox. 4; Skin Sens. 1
reaction mass of n-octadecylaminodiethyl bis(hydrogen maleate); n-octadecylaminodiethyl hydrogen maleate hydrogenphthalate ETHOXYLATED POLYESTER RESIN	405-960-8	-	Skin Sens. 1
reaction mass of mono to tetra(lithium and/or sodium)3-amino-10-[4-(4-amino-3-sulfonatoanilino)-6-[methyl-(2-sulfonatoethyl)amino]-1,3,5-triazin-2-ylamino]-6-13-dichlorobenzo[1,2-B:4,5-B']di[1,4]benzoxazine-4,11-disulfonate; mono to tetra(lithium and/or sodium)3-amino-10-[4,6-bis(4-amino-3-sulfonatoanilino)-1,3,5-triazin-2-ylamino]-6-13-dichlorobenzo[1,2-B:4,5-B']di[1,4]benzoxazine-4,11-disulfonate; mono to penta(lithium and/or sodium)10,10'-diamino-6,6',13,13'-tetrachloro-3,3'-[6-[methyl-(2-sulfonatoethyl)amino]-1,3,5-triazin-2,4-diyldiimino]bis[benzo[1,2-B:4,5-B']di[1,4]benzoxazine-4,11-disulfonate; mono to hepta(lithium and/or sodium)10-amino-6,6', 13,13'-tetrachloro-10'[4-(4-amino-3-sulfonatoanilino)-[6-methyl-(2-sulfonatoethyl)amino]-1,3,5-triazin-2,4-diimino]bis[benzo[1,2-B:4,5-B']di[1,4]benzoxazine-4,11-disulfonate; mono to hepta(lithium and/or sodium)10,10'-diamino-6,6',3,3'[(2-sulfonato)-1,4-phenylenediiminobis[6-methyl-(2-sulfonatoethyl)amino]-1,3,5-triazin-2,4-diyldiimino]bis[benzo[1,2-B:4,5-B']di[1,4]benzoxazine-4,11-disulfonate	430-200-7	-	Eye Dam. 1
reaction mass of isomers of: α-((dimethyl)biphenyl)-ω-hydroxypoly(oxyethylene) EMULGATOR SWA; EMULVIN SWA	406-325-8	-	Acute Tox. 4
reaction mass of isomers of: sodium phenethylnaphthalenesulfonate; sodium naphthylethylbenzenesulfonate UNISOL S	405-760-0	-	Eye Dam. 1; Skin Sens. 1
reaction mass of isomers of: sodium [(2-hydroxyethylsulfamoyl){][}2-(2-piperazin-1-ylethylamino)ethylsulfamoyl][2-(4-aminoethylpiperazine-1-yl)ethylsulfamoyl{](sulfamoyl)[}(sulfonatophthalocyaninato)]copper(II) SUBSTANCE S166075	424-270-8	-	Eye Dam. 1
reaction mass of isomers of: mono-(2-tetradecyl)naphthalenes; di-(2-tetradecyl)naphthalenes; tri-(2-tetradecyl)naphthalenes MCP 968	410-190-0	132983-41-6	Eye Irrit. 2
reaction mass of isomers of: methyldiphenylmethane; dimethyldiphenylmethane MARLOTHERM L	405-470-4	73807-39-3	Skin Irrit. 2
reaction mass of isomers of branched tetracosane 1-DODECENE DIMER, HYDROGENATED; ALKANE 2	417-060-2	151006-61-0	Acute Tox. 4
reaction mass of iron complexes of: 1,3-dihydroxy-4-[(5-phenylaminosulfonyl)-2-hydroxyphenylazo]-n-(5-amino-sulfonyl-2-hydroxyphenylazo)benzene; and: 1,3-dihydroxy-4-[(5-phenylaminosulfonyl)-2-hydroxyphenylazo]-n-[4-(4-nitro-2-sulfophenylamino)phenylazo]benzene (n=2,5,6) BROWN JR 543	414-150-3	-	Skin Sens. 1
reaction mass of esters of 5,5',6,6',7,7'-hexahydroxy-3,3,3',3'-tetramethyl-1,1'-spirobiindan and 2-diazo-1,2-dihydro-1-oxo-5-sulfonaphthalene PS-6 SENSITIZER	413-840-1	121870-66-4	Self-react. C
reaction mass of dodecyl 3-(2,2,4,4-tetramethyl-21-oxo-7-oxa-3,20-diazadispiro(5,1,11,2)henicosan-20-yl)propionate and tetradecyl 3-(2,2,4,4-tetramethyl-21-oxo-7-oxa-3,20-diazadispiro(5,1,11,2)henicosan-20-yl)propionate HOSTAVIN N 24; SANDUVOR 3050; VP SANDUVOR 3050	400-580-9	85099-50-9	Skin Irrit. 2
reaction mass of disodium 6-(2,4-dihydroxyphenylazo)-3-(4-(4-(2,4-dihydroxyphenylazo)anilino)-3-sulphonatophenylazo)-4-hydroxynaphthalene-2-sulphonate and disodium 6-(2,4-diaminophenylazo)-3-(4-(4-(2,4-diaminophenylazo)anilino)-3-sulphonatophenylazo)-4-hydroxynaphthalene-2-sulphonate and trisodium 6-(2,4-dihydroxyphenylazo)-3-(4-(4-(7-(2,4-dihydroxyphenylazo)-1-hydroxy-3-sulphonato-2-naphthylazo)anilino)-3-sulphonatophenylazo)-4-hydroxynaphthalene-2-sulphonate C.I. DIRECT BLACK 174	400-570-4	162994-84-5	Eye Irrit. 2
reaction mass of compounds from (dodecakis(p-tolylthio)phthalocyaninato)copper(II)to (hexadecakis(p-tolylthio)phthalocyaninato)copper(II) PROJET 780 NP; SUBSTANCE SC101756	407-700-9	101408-30-4	Skin Sens. 1
reaction mass of C12-14-tert-alkylammonium diphenyl phosphorothioate and dinonyl sulphide (or disulphide) X 3761	400-930-0	-	Skin Irrit. 2; Eye Dam. 1; Skin Sens. 1
reaction mass of 7-[4-(3-diethylaminopropylamino)-6-(3-diethylammoniopropylamino)-1,3,5-triazin-2-ylamino]-4-hydroxy-3-(4-phenylazophenylazo)-naphthalene-2-sulfonate, acetic acid, lactic acid (2:1:1) CARTASOL RED K-2BN; RED 10 25 501	408-000-6	118658-98-3	STOT RE 2; Skin Sens. 1
reaction mass of 5-heptyl-1,2,4- triazol-3-ylamine and 5-nonyl-1,2,4-triazol-3-ylamine PK 323	401-940-8	-	Acute Tox. 4; Eye Irrit. 2
Reaction mass of 5-(sec-butyl)-2-(2,4-dimethylcyclohex-3-en-1-yl)-5-methyl-1,3-dioxane and 5-(sec-butyl)-2-(4,6-dimethylcyclohex-3-en-1-yl)-5-methyl-1,3-dioxane;Reaction mass of 5-[(2R)-butan-2-yl]-2-[(1R,2R)-2,4-dimethylcyclohex-3-en-1-yl]-5-methyl-1,3-dioxane and 5-[(2R)-butan-2-yl]-2-[(1R,2S)-2,4-dimethylcyclohex-3-en-1-yl]-5-methyl-1,3-dioxane and 5-[(2R)-butan-2-yl]-2-[(1S,2R)-2,4-dimethylcyclohex-3-en-1-yl]-5-methyl-1,3-dioxane and 5-[(2R)-butan-2-yl]-2-[(1S,2S)-2,4-dimethylcyclohex-3-en-1-yl]-5-methyl-1,3-dioxane and 5-[(2S)-butan-2-yl]-2-[(1S,2R)-2,4-dimethylcyclohex-3-en-1-yl]-5-methyl-1,3-dioxane and 5-[(2S)-butan-2-yl]-2-[(1S,2S)-2,4-dimethylcyclohex-3-en-1-yl]-5-methyl-1,3-dioxane	413-720-9	117933-89-8			yes
Reaction mass of 5-(sec-butyl)-2-(2,4-dimethylcyclohex-3-en-1-yl)-5-methyl-1,3-dioxane and 5-(sec-butyl)-2-(4,6-dimethylcyclohex-3-en-1-yl)-5-methyl-1,3-dioxane;Reaction mass of 5-[(2R)-butan-2-yl]-2-[(1R,2R)-2,4-dimethylcyclohex-3-en-1-yl]-5-methyl-1,3-dioxane and 5-[(2R)-butan-2-yl]-2-[(1R,2S)-2,4-dimethylcyclohex-3-en-1-yl]-5-methyl-1,3-dioxane and 5-[(2R)-butan-2-yl]-2-[(1S,2R)-2,4-dimethylcyclohex-3-en-1-yl]-5-methyl-1,3-dioxane and 5-[(2R)-butan-2-yl]-2-[(1S,2S)-2,4-dimethylcyclohex-3-en-1-yl]-5-methyl-1,3-dioxane and 5-[(2S)-butan-2-yl]-2-[(1S,2R)-2,4-dimethylcyclohex-3-en-1-yl]-5-methyl-1,3-dioxane and 5-[(2S)-butan-2-yl]-2-[(1S,2S)-2,4-dimethylcyclohex-3-en-1-yl]-5-methyl-1,3-dioxane	413-720-9	117933-89-8			yes
Reaction mass of 2-ethylhexyl 10-ethyl-4,4-dioctyl-7-oxo-8-oxa-3,5-dithia-4-stannatetradecanoate and 2-ethylhexyl 10-ethyl-4-[[2-[(2-ethylhexyl)oxy]-2-oxoethyl]thio]-4-octyl-7-oxo-8-oxa-3,5-dithia-4-stannatetradecanoate; reaction mass of DOTE and MOTE	915-270-3	-			yes
reaction mass of 2-chloroethyl chloropropyl 2-chloroethylphosphonate, reaction mass of isomers and 2-chloroethyl chloropropyl 2-chloropropylphosphonate, reaction mass of isomers ADINE CP 31	401-740-0	-	Acute Tox. 4
reaction mass of 2-acryloyloxyethyl hydrogen cyclohexane-1,2-dicarboxylate and 2-methacryloyloxyethyl hydrogen cyclohexane-1,2-dicarboxylate KAYARAD R-825	405-360-6	-	Skin Irrit. 2; Eye Dam. 1; Skin Sens. 1
reaction mass of 2,2-iminodiethanol 6-methyl-2-(4-(2,4,6-triaminopyrimidin-5-ylazo)phenyl)benzothiazole-7-sulfonate and 2-methylaminoethanol 6-methyl-2-(4-(2,4,6-triaminopyrimidin-5-ylazo)phenyl)benzothiazole-7-sulfonate and N, N-diethylpropane-1,3-diamine 6-methyl-2-(4-(2,4,6-triaminopyrimidin-5-ylazo)phenyl)benzothiazole-7-sulfonate C.I. DIRECT YELLOW 166; DIRECT YELLOW 166; GIALLO DIRETTO 166; JAUNE DIRECT 166; MONOAZO YELLOW MA 2822	403-410-1	114565-65-0	Skin Sens. 1
reaction mass of 1-[2-(2-aminobutoxy)ethoxy]but-2-ylamine and 1-({[2-(2-aminobutoxy)ethoxy]methyl}propoxy)but-2-ylamine	447-920-2	897393-42-9	Repr. 2; Acute Tox. 4; Skin Corr. 1B; Eye Dam. 1
reaction mass of 1,1'-(methylenebis(4,1-phenylene))dipyrrole-2,5-dione and N-(4-(4-(2,5-dioxopyrrol-1-yl)benzyl)phenyl)acetamide and 1-(4-(4-(5- oxo-2H-2-furylide namino)benzyl)phenyl)pyrrole-2,5-dione DESBIMID	401-970-1	-	Skin Sens. 1
reaction mass of 1,1'-((dihydroxyphenylene)bis(azo-3,1-phenylenazo(1-(3-dimethylaminopropyl)-1,2-dihydro-6-hydroxy-4-methyl-2-oxopyridine-5,3-diyl)))dipyridinium dichloride dihydrochloride, mixed isomers and 1-(1-(3-dimethylaminopropyl)-5-(3-((4-(1-(3-dimethylaminopropyl)-1,6-dihydro-2-hydroxy-4-methyl-6-oxo-5-pyridinio-3-pyridylazo)phenylazo)-2,4(or 2,6 or 3,5)-dihydroxyphenylazo)phenylazo)-1,2-dihydro-6-hydroxy-4-methyl-2-oxo-3-pyridyl)pyridinium dichloride BRAUN HM 2763; BROWN HM 2763; BRUN HM 2763; BRUNO HM 2763	404-540-1	-	Skin Sens. 1
reaction mass of (S)-Indoxacarb and (R)-Indoxacarb 75:25; methyl 7-chloro-2-{(methoxycarbonyl)[4-(trifluoromethoxy)phenyl]carbamoyl}-2,5-dihydroindeno[1,2-e][1,3,4]oxadiazine-4a(3H)-carboxylate [2]	604-398-2	144171-61-9	Acute Tox. 3; Acute Tox. 4; STOT RE 1; Skin Sens. 1B
reaction mass (ratio not known) of: ammonium 1-C14-C18-alkyloxycarbonyl-2-(3-allyloxy-2-hydroxypropoxycarbonyl)ethane-1-sulfonate; ammonium 2-C14-C18-alkyloxycarbonyl-1-(3-allyloxy-2-hydroxypropoxycarbonyl)ethane-1-sulfonate LATEMUL S-180 A	410-540-2	116726-92-2	Skin Irrit. 2; Skin Sens. 1
reaction mas of: 7-amino-3,8-bis-[4-(2-sulfoxyethylsulfonyl)phenylazo]-4-hydroxynaphthalene-2-sulfonic acid, Na/K salt; 7-amino-3-[4-(2-sulfoxyethylsulfonyl)phenylazo]-4-hydroxy-8-[4-(2-sulfoxyethylsulfonyl)-2-sulfophenylazo]naphthalene-2-sulfonic acid, Na/K salt; 7-amino-8-[4-(2-sulfoxyethylsulfonyl)-phenylazo]-4-hydroxy-3-[4-(2-sulfoxyethylsulfonyl)-2-sulfophenylazo]naphthalene-2-sulfonic acid, Na/K salt; 7-amino-3,8-bis-[4-(2-sulfoxyethylsulfonyl)-2-sulfophenylazo]-4-hydroxynaphthalene-2-sulfonic acid, Na/K salt SCARLET DER 8107	429-070-4	214362-06-8	Eye Dam. 1
Raffinates (petroleum), steam-cracked C4 fraction cuprous ammonium acetate extn., C3-5 and C3-5 unsatd., butadiene-free; Petroleum gas	307-769-4	97722-19-5	Press. Gas; Flam. Gas 1; Carc. 1A; Muta. 1B
Raffinates (petroleum), reformer, Lurgi unit-sepd.; Low boiling point modified naphtha [he complex combination of hydrocarbons obtained as a raffinate from a Lurgi separation unit. It consists predominantly of non-aromatic hydrocarbons with various small amounts of aromatic hydrocarbons having carbon numbers predominantly in the range of C6 through C8.] The complex combination of hydrocarbons obtained as a raffinate from a Lurgi separation unit. It consists predominantly of non-aromatic hydrocarbons with various small amounts of aromatic hydrocarbons having carbon numbers predominantly in the range of C6 through C8.	270-349-3	68425-35-4	Carc. 1B; Muta. 1B; Asp. Tox. 1
Raffinates (petroleum), catalytic reformer ethylene glycol-water countercurrent exts.; Low boiling point modified naphtha [ complex combination of hydrocarbons obtained as the raffinate from the UDEX extraction process on the catalytic reformer stream. It consists of saturated hydrocarbons having carbon numbers predominantly in the range of C6 through C9.] A complex combination of hydrocarbons obtained as the raffinate from the UDEX extraction process on the catalytic reformer stream. It consists of saturated hydrocarbons having carbon numbers predominantly in the range of C6 through C9.	270-088-5	68410-71-9	Carc. 1B; Muta. 1B; Asp. Tox. 1
Rabies virus	-	-		V Viruses: Member States are to ensure that all viruses which have already been isolated in humains and which have not been assessed and allocated in this Annex are classified in group 2 as a minimum, except where Member States have proof that they are unlikely to cause disease in humans.
Rabbitpox virus	-	-		V Viruses: Member States are to ensure that all viruses which have already been isolated in humains and which have not been assessed and allocated in this Annex are classified in group 2 as a minimum, except where Member States have proof that they are unlikely to cause disease in humans.
R-1-chloro-2,3-epoxypropane (R)-EPICHLOROHYDRIN	424-280-2	51594-55-9	Flam. Liq. 3; Carc. 1B; Acute Tox. 3; Skin Corr. 1B; Skin Sens. 1
R, R-2-hydroxy-5-(1-hydroxy-2-(4-phenylbut-2-ylamino)ethyl)benzamide hydrogen 2,3-bis(benzoyloxy)succinate SCH.19927 DIBENZOYLTARTRATE	404-390-7	88976-55-0	Flam. Sol. 1; Skin Sens. 1
quizalofop-P-tefuryl (ISO); (±) tetrahydrofurfuryl (R)-2-[4-(6-chloroquinoxalin-2-yloxy)phenyloxy]propionate PANTERA; QUIZALOFOP-P-TEFURYL	414-200-4	119738-06-6	Carc. 2; Repr. 2; Acute Tox. 4; STOT RE 2
quintozene (ISO); pentachloronitrobenzene	201-435-0	82-68-8	Skin Sens. 1
quinoxyfen (ISO);5,7-dichloro-4-(4-fluorophenoxy)quinoline	602-997-3	124495-18-7	Skin Sens. 1
quinomethionate; chinomethionat (ISO); 6-methyl-1,3-dithiolo(4,5-b)quinoxalin-2-one	219-455-3	2439-01-2	Repr. 2; Acute Tox. 4; STOT RE 2; Eye Irrit. 2; Skin Sens. 1
quinoline	202-051-6	91-22-5	Carc. 1B; Muta. 2; Acute Tox. 4; Eye Irrit. 2; Skin Irrit. 2
quinolin-8-ol; 8-hydroxyquinoline	205-711-1	148-24-3	Repr. 1B; Acute Tox. 3; Eye Dam. 1; Skin Sens. 1
quinclorac (ISO); 3,7-dichloroquinoline-8-carboxylic acid BAS 514 H	402-780-1	84087-01-4	Skin Sens. 1
quinalphos (ISO); O, O-diethyl-O-quinoxalin-2-yl phosphorothioate	237-031-6	13593-03-8	Acute Tox. 3; Acute Tox. 4
quaternary ammonium compounds, benzyl-C8-18-alkyldimethyl, chlorides	264-151-6	63449-41-2	Acute Tox. 4; Skin Corr. 1B
pyroxsulam (ISO); N-(5,7-dimethoxy[1,2,4]triazolo[1,5-a]pyrimidin-2-yl)-2-methoxy-4-(trifluoromethyl)pyridine-3-sulfonamide	610-007-6	422556-08-9	Skin Sens. 1
pyroquilon (ISO);1,2,5,6-tetrahydropyrrolo[3,2,1- ij]quinolin-4-one	611-516-6	57369-32-1	Acute Tox. 4
pyrogallol; 1,2,3-trihydroxybenzene	201-762-9	87-66-1	Muta. 2; Acute Tox. 4
Pyrochlore, antimony lead yellow This substance is identified in the Colour Index by Colour Index Constitution Number, C.I. 77588.	232-382-1	8012-00-8			yes
pyrithione zinc; (T-4)-bis[1-(hydroxy-κO)pyridine-2(1H)-thionato-κS]zinc	236-671-3	13463-41-7	Repr. 1B; Acute Tox. 2; Acute Tox. 3; STOT RE 1; Eye Dam. 1
Pyridine, alkyl derivs.; Crude Tar Bases [The complex combination of polyalkylated pyridines derived from coal tar distillation or as high-boiling distillates approxi mately above 150o C (302oF) from the reaction of ammonia with acetaldehyde, formaldehyde or paraformaldehyde.] The complex combination of polyalkylated pyridines derived from coal tar distillation or as high-boiling distillates approximately above 150°C (302°F) from the reaction of ammonia with acetaldehyde, formaldehyde or paraformaldehyde.	269-929-9	68391-11-7	Carc. 1B; Muta. 1B
pyridine	203-809-9	110-86-1	Flam. Liq. 2; Acute Tox. 4
pyridate (ISO); O-(6-chloro-3-phenylpyridazin-4-yl) S-octyl thiocarbonate	259-686-7	55512-33-9	Acute Tox. 4; Skin Irrit. 2; Skin Sens. 1
pyridaben (ISO); 2-tert-butyl-5-(4-tert-butylbenzylthio)-4-chloropyridazin-3(2H)-one PYRIDABEN	405-700-3	96489-71-3	Acute Tox. 3
pyrethrins including cinerins, with the exception of those specified elsewhere in this Annex	-	-	Acute Tox. 4
Pyrene	204-927-3	129-00-0			yes
pyrazoxon; diethyl 3-methylpyrazol-5-yl phosphate	-	108-34-9	Acute Tox. 2; Acute Tox. 1
pyrazophos (ISO); O, O-diethyl O-(6-ethoxycarbonyl-5-methylpyrazolo[2,3-a]pyrimidin-2-yl) phosphorothioate	236-656-1	13457-18-6	Acute Tox. 4
pyrazole-1-carboxamidine monohydrochloride	429-520-1	4023-02-3	Acute Tox. 4; STOT RE 2; Eye Dam. 1; Skin Sens. 1
pyraclostrobin (ISO); methyl N-{2-[1-(4-chlorophenyl)-1H-pyrazol-3-yloxymethyl]phenyl}(N-methoxy)carbamate	605-747-1	175013-18-0	Acute Tox. 3; Skin Irrit. 2
pymetrozine (ISO); (E)-4,5-dihydro-6-methyl-4-(3-pyridylmethyleneamino)-1,2,4-triazin-3(2H)-one	602-927-1	123312-89-0	Carc. 2; Repr. 2
Puumala virus	-	-		V Viruses: Member States are to ensure that all viruses which have already been isolated in humains and which have not been assessed and allocated in this Annex are classified in group 2 as a minimum, except where Member States have proof that they are unlikely to cause disease in humans.
Pseudomonas aeruginosa	-	68583-29-9		B Bacteria and similar species
proxan-sodium (ISO); sodium O-isopropyldithiocarbonate	205-443-5	140-93-2	Acute Tox. 4; Skin Irrit. 2
Providencia spp.	-	-		B Bacteria and similar species
Providencia rettgeri	-	-		B Bacteria and similar species
Providencia alcalifaciens	-	-		B Bacteria and similar species
prothoate (ISO); O,O-diethyl isopropylcarbamoylmethyl phosphorodithioate	218-893-2	2275-18-5	Acute Tox. 1; Acute Tox. 2
Proteus vulgaris	-	-		B Bacteria and similar species
Proteus penneri	-	-		B Bacteria and similar species
Proteus mirabilis	-	-		B Bacteria and similar species
proteinase, microbial neutral	232-966-6	9068-59-1	Eye Irrit. 2; STOT SE 3; Skin Irrit. 2; Resp. Sens. 1
proteases with the exception of those specified elsewhere in this Annex show/hide Proteinase, Endothia aspartic EC / List no: 253-395-9 \| CAS no: 37205-60-0 Proteinase, bacterial E 30 serine EC / List no: - \| CAS no: 39369-34-1 Proteinase, Aspergillus alkaline EC / List no: 232-977-6 \| CAS no: 9074-07-1 Proteinase, Myxobacter α-lytic EC / List no: 253-448-6 \| CAS no: 37288-76-9 Proteinase, Aspergillus parasiticus neutral EC / List no: 254-418-5 \| CAS no: 39335-09-6 Proteinase, Bothrops atrox serine EC / List no: 232-918-4 \| CAS no: 9039-61-6 Amylase, mixture with proteinase EC / List no: 685-079-5 \| CAS no: 9001-11-0 Proteinase, pancreatic EC / List no: 232-626-7 \| CAS no: 9001-72-3 Myxobacteralphalyticproteinase EC / List no: - \| CAS no: 12585-31-8 Proteinase, Aspergillus neutral EC / List no: 278-588-5 \| CAS no: 77000-13-6 Proteinase, Bacillus subtilis EC / List no: 257-520-8 \| CAS no: 51931-23-8 Proteinase, Agkistrodon serine EC / List no: 232-933-6 \| CAS no: 9046-56-4 Proteinase, Bacillus alkaline EC / List no: 232-972-9 \| CAS no: 9073-77-2 Proteinase, microbial acid EC / List no: 256-862-5 \| CAS no: 50936-52-2 Proteinase, Bacillus subtilis metallo- EC / List no: 232-991-2 \| CAS no: 9080-56-2 Proteinase, Bacillus licheniformis serine EC / List no: 279-361-3 \| CAS no: 79986-26-8 Proteinase, oryzin EC / List no: 232-992-8 \| CAS no: 9081-30-5 Proteinase, Staphylococcus aureus serine EC / List no: 259-611-8 \| CAS no: 55354-32-0 Proteinase, Bacillus alcalophilus serine EC / List no: 306-090-0 \| CAS no: 95979-76-3 Proteinase, Aspergillus acid EC / List no: 232-796-2 \| CAS no: 9025-49-4 Proteinase, microbial alkaline EC / List no: 256-863-0 \| CAS no: 50936-53-3 Proteinase, rhizopus acid EC / List no: 812-486-9 \| CAS no: 9074-09-3 Proteinase, serine EC / List no: 253-431-3 \| CAS no: 37259-58-8 Proteinase, submandibular gland serine, A EC / List no: 279-893-6 \| CAS no: 82047-85-6 Proteinase, Tritirachium album serine EC / List no: 254-457-8 \| CAS no: 39450-01-6 Proteinase, Bacillus subtilis, sutilain EC / List no: 235-390-3 \| CAS no: 12211-28-8 Thrombin EC / List no: 232-648-7 \| CAS no: 9002-04-4 Aspergillin M EC / List no: - \| CAS no: 42615-60-1 Proteinase, aspartic EC / List no: 278-856-1 \| CAS no: 78169-47-8 Proteinase, Streptomyces griseus EC / List no: 232-909-5 \| CAS no: 9036-06-0 Proteinase, Myxobacter AL-1, II EC / List no: 276-716-4 \| CAS no: 72561-05-8 Bacteria, complex with amylase and proteinase EC / List no: - \| CAS no: 68920-42-3 Amylase, mixed with proteinase, Bacillus cereus-fermented EC / List no: - \| CAS no: 68909-35-3 Proteinase, Aspergillus melleus, semialkaline EC / List no: - \| CAS no: 76106-83-7 Proteinase, serine (Tritirachium album) EC / List no: 686-165-5 \| CAS no: 102925-54-2 Proteinase, microbial neutral EC / List no: 232-966-6 \| CAS no: 9068-59-1 Proteinase, Bacillus subtilis serine EC / List no: 266-557-9 \| CAS no: 67051-83-6 Proteinase, Serratia extracellular EC / List no: 253-457-5 \| CAS no: 37312-62-2 Bacillus megaterium protease fermentation product EC / List no: - \| CAS no: 68909-17-1 Proteinase, Bacillus neutral EC / List no: 278-547-1 \| CAS no: 76774-43-1 Amylase, mixed with proteinase, Bacillus thuringiensis-fermented EC / List no: - \| CAS no: 68909-36-4 Proteinase, Aspergillus niger neutral EC / List no: 254-422-7 \| CAS no: 39346-39-9 Proteinase, Mucor aspartic EC / List no: 232-975-5 \| CAS no: 9073-79-4 Proteinase, Bacillus polymyxa neutral EC / List no: 255-914-4 \| CAS no: 42613-33-2 Proteinase, Aspergillus oryzae neutral EC / List no: 232-990-7 \| CAS no: 9080-55-1	934-013-6	39450-01-6	Eye Irrit. 2; STOT SE 3; Skin Irrit. 2; Resp. Sens. 1
prosulfuron (ISO); 1-(4-methoxy-6-methyl-1,3,5-triazin-2-yl)-3-[2-(3,3,3-trifluoropropyl)phenylsulfonyl]urea	619-000-2	94125-34-5	Acute Tox. 4
prosulfocarb (ISO); S-benzyl N, N-dipropylthiocarbamate PROSULFOCARB	401-730-6	52888-80-9	Acute Tox. 4; Skin Sens. 1
Prospect Hill virus	-	-		V Viruses: Member States are to ensure that all viruses which have already been isolated in humains and which have not been assessed and allocated in this Annex are classified in group 2 as a minimum, except where Member States have proof that they are unlikely to cause disease in humans.
proquinazid (ISO); 6-iodo-2-propoxy-3-propylquinazolin-4(3H)-one	606-168-7	189278-12-4	Carc. 2
propyzamide (ISO); 3,5-dichloro-N-(1,1-dimethylprop-2-ynyl)benzamide	245-951-4	23950-58-5	Carc. 2
propylenethiourea	620-432-9	2122-19-2	Repr. 2; Acute Tox. 4
propylenediamine	201-155-9	78-90-0	Flam. Liq. 3; Acute Tox. 4; Skin Corr. 1A
propylene oxide; 1,2-epoxypropane; methyloxirane	200-879-2	75-56-9	Flam. Liq. 1; Carc. 1B; Muta. 1B; Acute Tox. 3; Acute Tox. 4; Eye Irrit. 2; STOT SE 3		yes
propylene carbonate	203-572-1	108-32-7	Eye Irrit. 2

Prikazano 901 - 1.000 od 4.821 rezultata.

Export search results to:

EU-IN_VITRO_MEDICAL_DEVICES-ART_3_ANX_1

EU-IN_VITRO_MEDICAL_DEVICES-ART_3_ANX_1

In Vitro Diagnostic Medical Devices Directive - Hazardous Substances

EU. Hazardous Substances for Purposes of Article 3 & Annex I (Essential Requirements), Directive 98/79/EC on In Vitro Diagnostic Medical Devices, 7 December 1998

RELEVANT LEGISLATION

Contact EUCLEF Helpdesk

Contact Helpdesk

Last updated 04 listopada 2024. Database contains 4821 unique substances/entries.

Footer Nav Items